COST-MINIMIZATION ANALYSIS OF ADDING A NEW SINGLE INHALER TRIPLE THERAPY (SITT) FOR THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UK

被引：1
|
作者：
Schroeder, M. [1 ]
Shah, D. [2 ]
Risebrough, N. [3 ]
Ndirangu, K. [2 ]
Martin, A. A. [4 ]
Ismaila, A. [5 ]
机构：
[1] GSK, Brentford, England
[2] ICON Plc, New York, NY USA
[3] ICON Plc, ICON Hlth Econ, Toronto, ON, Canada
[4] GSK, Uxbridge, Middx, England
[5] GSK, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1595
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PR532
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [21] ECONOMIC ANALYSIS OF NEW SINGLE-INHALER TRIPLE THERAPIES IN PATIENTS WITH COPD IN THE UK
    Cai, R.
    Martin, A.
    Ge, Y.
    Risebrough, N.
    Sharma, R.
    Haeussler, K.
    Compton, C.
    Halpin, D.
    Ismaila, A. S.
    VALUE IN HEALTH, 2022, 25 (12) : S183 - S184
  • [22] Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
    Huanyu Long
    Hongxuan Xu
    Jean-Paul Janssens
    Yanfei Guo
    Respiratory Research, 22
  • [23] Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
    Long, Huanyu
    Xu, Hongxuan
    Janssens, Jean-Paul
    Guo, Yanfei
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [24] COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Benjamin, N.
    Huerta, A.
    Biswas, C.
    Schroeder, M.
    Whalen, J.
    Izquierdo Alonso, J. L.
    Soler Cataluna, J. J.
    Riesco Miranda, J. A.
    Martin, A.
    Atienza, L.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S3 - S3
  • [25] Cost-effectiveness of single-inhaler triple therapy for chronic obstructive pulmonary disease treatment by baseline blood eosinophil count: IMPACT trial
    Shah, Dhvani
    Martin, Alan
    Kendall, Robyn
    Risebrough, Nancy
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [26] Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice
    Sansbury, Leah B.
    Bains, Chanchal
    Lipson, David A.
    Ismaila, Afisi S.
    Landis, Sarah H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1255 - 1264
  • [27] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Vallejo-Aparicio, L. A.
    Paly, V. F.
    Schroeder, M.
    Martin, A.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S878 - S878
  • [28] Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
    Martin, Alan
    Shah, Dhvani
    Ndirangu, Kerigo
    Anley, Glenn A.
    Okorogheye, Gabriel
    Schroeder, Melanie
    Risebrough, Nancy
    Ismaila, Afisi S.
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [29] Inhaled Triple Therapy in Severe Chronic Obstructive Pulmonary Disease (COPD)
    Gillissen, A.
    Paparoupa, M.
    Frings, D.
    Atique, B.
    Koczulla, R.
    PNEUMOLOGIE, 2018, 72 (12): : 832 - 842
  • [30] Efficacy and Safety of Single Inhaler Triple Therapy Versus Separate Triple Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
    Zhang, Liansheng
    Wang, Xiaoqing
    Zhang, Ye
    Chen, Wenyu
    CLINICAL THERAPEUTICS, 2022, 44 (06) : 859 - +
12345